Restructural changes effective immediately.
The editorial teams of Pharmaceutical Executive and Pharmaceutical Commerce are excited to announce the following updates:
Mike Hollan (MHollan@mjhlifesciences.com) has been named editor of Pharmaceutical Executive, handling the technology and leadership columns, as well as general industry articles and interviews.
Meg Rivers (MRivers@mjhlifesciences.com) has been named managing editor of Pharmaceutical Executive and will be responsible for the day-to-day management and content direction of the brand. Formerly, Meg was the senior editor for our sister brands, Pharmaceutical Technology and BioPharm International, since June 2021. There, she interviewed industry leaders for print and online features, roundtables, and conferences, in addition to managing/co-hosting the biweekly Pharmaceutical Technology podcast, the Drug Solutions Podcast, as well as the Drug Digest video series.
Nico Saraceno (NSaraceno@mjhlifesciences.com) has been promoted to editor of Pharmaceutical Commerce. As associate editor since October 2020, Nico has successfully produced the Pharmaceutical Commerce podcast, taken on increasing responsibilities, and is now leading the day-to-day content management of the brand.
The State of Mining Data Insights in the Life Sciences Industry – 2024
April 30th 2024A Frost & Sullivan industry-wide survey reveals which insights most pharmaceutical companies have mastered and which are still painful or impossible to extract and details the complexity of the process, the confidence companies have in their findings, and more. Hear Web Sun, President and Co-founder of Komodo Health, share what's driving these challenges and how you can overcome them.